skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

49 studies were found about Complicaciones, Demencia

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

Condition: HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections; Healthy

NCT ID: NCT00459693

Minocycline for HIV+ Cognitive Impairment in Uganda

Condition: HIV-associated Cognitive Impairment; HIV Infections

NCT ID: NCT00855062

A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases

Condition: AIDS Dementia Complex; Neuromuscular Diseases; HIV Infections

NCT ID: NCT00002044

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00000702

Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia

Condition: HIV Infections

NCT ID: NCT00002414

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002209

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00000738

Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia

Condition: Cognitive Disorders; HIV Infections

NCT ID: NCT00002148

A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV

Condition: HIV Dementia

NCT ID: NCT01599975

A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia

Condition: Cognitive Disorders; HIV Infections

NCT ID: NCT00002154

A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00000867

Modulation of Monocyte Activation by Atorvastatin in HIV Infection

Condition: HIV Dementia

NCT ID: NCT01263938

Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders

Condition: HIV Dementia

NCT ID: NCT01665846

Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)

Condition: HIV Dementia

NCT ID: NCT01600170

HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia

Condition: HIV Infections

NCT ID: NCT00777426

Mild Neurocognitive Disorder in HIV Infection of the Brain

Condition: HIV-Associated Cognitive Motor Complex

NCT ID: NCT01547754

A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002163

An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00000709

A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002246

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00000657

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

Condition: HIV Infections

NCT ID: NCT00476671

A Study of Decreased Mental Function Associated With HIV

Condition: Cognitive Disorders; HIV Infections

NCT ID: NCT00027040

Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients

Condition: Cognition Disorders; HIV Infections

NCT ID: NCT00013585

HIV - Monotherapy in Switzerland (MOST-ch)

Condition: HIV Infections

NCT ID: NCT00531986

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

Condition: HIV Infections

NCT ID: NCT00096824

Efficacy of Neuro-HAART in Patients With HIV

Condition: HIV

NCT ID: NCT01434654

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

Condition: HIV Infections

NCT ID: NCT00002033

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

Condition: HIV Infections; Central Nervous System Diseases; Dementia

NCT ID: NCT01340950

Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients

Condition: HIV Infections; Memory

NCT ID: NCT00893815

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

Condition: HIV Infections

NCT ID: NCT00987948

The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -

Condition: HIV-1-Associated Cognitive Motor Complex

NCT ID: NCT01434563

Multidisciplinary Inpatient Palliative Care Intervention

Condition: Cerebrovascular Accident; Cancer; Coronary Arteriosclerosis; Heart Failure, Congestive; Diabetes Mellitus; Acquired Immunodeficiency Syndrome; Failure to Thrive; Pulmonary Disease, Chronic Obstructive; Dementia; Kidney Failure, Chronic; Pneumonia; Liver Failure; Renal Failure; Respiratory Failure; Stroke

NCT ID: NCT00325611

Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder

Condition: HIV Associated Neurocognitive Disorder

NCT ID: NCT01354314

Predictors of Neuro-cognitive Decline and Survival in HIV-infected Subjects

Condition: AIDS; Dementia

NCT ID: NCT00864292

Brain Imaging for HIV-Associated Thinking and Mood Disorders

Condition: Human Immunodeficiency Virus; Neurocognitive Impairment

NCT ID: NCT01692236

CNS Viral Dynamics and Cellular Immunity During AIDS

Condition: HIV Infections

NCT ID: NCT00583167

Neurocognitive Assessment in Youth Initiating HAART

Condition: HIV Infections

NCT ID: NCT00683579

Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)

Condition: HIV Infections

NCT ID: NCT00002063

Notification of Donors With Positive Microbiology Markers

Condition: Human Immunodeficiency Virus; Hepatitis B; Hepatitis C; Human T-lymphotropic Virus I & II; Creutzfeldt-Jakob Syndrome; HIV Infections

NCT ID: NCT01050881

HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs

Condition: Cognitive Disorders; HIV Infections

NCT ID: NCT00001103

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study

Condition: Neurocognitive Disturbance; HIV Infection

NCT ID: NCT01348282

A Study of Azidothymidine in HIV-Infected Children

Condition: Encephalopathies; HIV Infections

NCT ID: NCT00000982

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

Condition: HIV Infections; Cognition Disorders

NCT ID: NCT00000392

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

Condition: HIV Infections; Cognition Disorders

NCT ID: NCT00000393

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

Condition: HIV; Impaired Cognition

NCT ID: NCT01367236

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Condition: Impaired Cognition; Depression/Anxiety; Poor Quality Sleep; Quality of Life; HIV-1 Infection

NCT ID: NCT02042001

The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)

Condition: HIV Infections; Depression; Mild Cognitive Impairment

NCT ID: NCT01246804

A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

Condition: Encephalopathy; HIV Infections; Radiculitis

NCT ID: NCT00000856